Found: 13
Select item for more details and to access through your institution.
Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0631-3
- By:
- Publication type:
- Article
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 1, p. 61, doi. 10.1007/s10549-023-07223-4
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. e71, doi. 10.1111/bjh.17996
- By:
- Publication type:
- Article
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1680, doi. 10.1002/ajh.27378
- By:
- Publication type:
- Article
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 10, p. 11248, doi. 10.1002/cam4.5832
- By:
- Publication type:
- Article
Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 8, p. 537, doi. 10.1016/j.clml.2024.03.013
- By:
- Publication type:
- Article
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using <sup>90</sup>Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e268, doi. 10.1016/j.clml.2023.05.011
- By:
- Publication type:
- Article
ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S276, doi. 10.1016/S2152-2650(21)01666-9
- By:
- Publication type:
- Article
Poster: ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S208, doi. 10.1016/S2152-2650(21)01305-7
- By:
- Publication type:
- Article
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 699, doi. 10.1093/oncolo/oyad036
- By:
- Publication type:
- Article
Factors Affecting Survival in Patients with Anal Melanoma.
- Published in:
- American Surgeon, 2006, v. 72, n. 10, p. 917, doi. 10.1177/000313480607201017
- By:
- Publication type:
- Article
A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 727, doi. 10.1002/cncr.35077
- By:
- Publication type:
- Article